Personalised medicine in asthma: time for action
Kian Fan Chung
European Respiratory Review 2017 26: 170064; DOI: 10.1183/16000617.0064-2017
Kian Fan Chung
1National Heart and Lung Institute, Imperial College London, London, UK
2Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UK
Vol 26 Issue 145
Table of Contents
Personalised medicine in asthma: time for action
Kian Fan Chung
European Respiratory Review Sep 2017, 26 (145) 170064; DOI: 10.1183/16000617.0064-2017
Jump To
- Article
- Abstract
- Abstract
- Introduction
- What is personalised medicine?
- Clinical phenotyping of asthma
- Unbiased molecular phenotyping using transcriptomics
- Genetic profiling
- Definition of a severe eosinophilic asthma phenotype/endotype?
- Biomarkers for personalised asthma: current and future biomarkers
- Monitoring asthma: use of mHealth for personalised medicine
- Conclusion
- Disclosures
- Footnotes
- References
- Figures & Data
- Info & Metrics